Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (AKR1C3)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9714266
APP PUB NO 20160024142A1
SERIAL NO

14770444

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to AKR1C3 inhibitors of formula (I) and to processes for preparation thereof, to the use thereof for treatment and/or prophylaxis of diseases and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of bleeding disorders and endometriosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYER PHARMA AKTIENGESELLSCHAFTMÜLLERSTR 178 BERLIN 13353

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barak, Naomi Berlin, DE 12 2
Bothe, Ulrich Berlin, DE 38 212
Busemann, Matthias Berlin, DE 5 3
Fischer, Oliver Martin Berlin, DE 15 23
Marquardt, Tobias Wuppertal, DE 38 77
Rotgeri, Andrea Berlin, DE 40 270

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 25, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 25, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00